BridgeBio Pharma

BridgeBio Builds on Positive Phase III Data for Acoramidis in ATTR-CM
BioSpace
Thu, 05/30/24 - 11:30 am
BridgeBio Pharma
acoramidis
clinical trials
ATTR-CM
2 Biotechs That Could Get Bought Out in 2024
Yahoo/Motley Fool
Wed, 01/3/24 - 04:59 pm
M&A
BridgeBio Pharma
Cytokinetics
BridgeBio makes $250M in securities sale while planning acoramidis commercial launch
Fierce Biotech
Mon, 09/25/23 - 11:51 am
BridgeBio Pharma
acoramidis
BridgeBio bounces back? Phase 2 readout provides hope for approval of drug to rebalance calcium levels
Fierce Biotech
Tue, 06/14/22 - 11:31 am
BridgeBio Pharma
clinical trials
encaleret
autosomal dominant hypocalcemia
After layoffs, BridgeBio turns to dealmaking for up to 6 drugs
Fierce Biotech
Fri, 05/6/22 - 10:52 am
BridgeBio Pharma
layoffs
restructuring
out-licensing
BridgeBio plots path to market for muscular dystrophy drug after posting phase 2 data
Fierce Biotech
Mon, 03/14/22 - 10:22 am
BridgeBio Pharma
limb-girdle muscular dystrophy
clinical trials
BBP-418
Biopharma developments over the Christmas period
EP Vantage
Mon, 01/3/22 - 10:26 am
Alnylam Pharmaceuticals
Bio-Thera Solutions
BioArctic
Biogen
BridgeBio Pharma
Daiichi Sankyo
Eisai
JNJ
Madrigal Pharmaceuticals
Merck
Sutro BioPharma
Tasly Pharmaceutical Group